Ernesto P. Chanona, Ph.D. has joined CSSi LifeScience as Director of Business Development. His role will be to find opportunities by developing strategic partnerships with innovation hubs, incubators, entrepreneurs, government agencies, and academic researchers. Some of the company’s clients are overseas, so he will be contributing to the relationship management of their global government partners. Internally, he will be part of the marketing and operations teams, helping to shape the company’s message and helping to grow the business development department.
Aron Starosta, Ph.D. Joins University City Science Center As Vice President, Commercialization and New Ventures
ARON STAROSTA, PH.D. JOINS UNIVERSITY CITY SCIENCE CENTER AS VICE PRESIDENT, COMMERCIALIZATION AND NEW VENTURES
CRB is excited to welcome Alex Moore as a Senior Biopharma Specialist in the Maryland office. Moore has over twenty-two years of industry experience and has focused his time within the manufacturing engineering and facilities engineering fields.
Spark Therapeutics Expands Visionary Leadership with Appointment of Michael Retterath as Chief Strategy Officer
Spark Therapeutics, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease, today announced the appointment of Michael Retterath as chief strategy officer.
Peter Dedivanovic joins Workforce Genetics as a Senior Life Sciences Talent Consultant
Nautilus Biotechnology, a company pioneering a high-throughput, low-cost platform for quantifying the human proteome, today announced the appointment of Nick Nelson as Chief Business Officer.
ABL, Inc. (ABL), a leading global viral vector contract manufacturing and research testing service provider to the biopharmaceutical industry, announces the hire of Diana Elias as HR Director.
Reinhard is the Chairman of Scientific Bioprocessing Inc. and serves on the Board of our parent company, Scientific Industries.
Veralox Therapeutics Appoints Life Sciences Industry Veteran Alex Martin as Chairman of the Board of Directors
Mr. Martin brings to the Chairman’s role over 25 years of experience in senior executive roles in the life sciences industry, with a focus on business development, operations, and financing.
Amanda L. Murphy Appointed as Chief Financial Officer to MaxCyte